ArticleJournal of translational medicine2020

Cytoplasmic PPARγ is a marker of poor prognosis in patients with Cox-1 negative primary breast cancers.

Wanting Shao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.